Back
EHRA Premium Access

Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients

Session: Atrial Fibrillation - Round 6 - Mechanisms - Pathophysiology
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor A. Fawzy (Liverpool, GB)
Event: EHRA 2023

Congress Presentation

About the speaker

Doctor Ameenathul Mazaya Fawzy

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

8 more presentations in this session

Associations of general and abdominal obesity, and genetic risk with atrial fibrillation: longitudinal analyses in the UK biobank study

Speaker: Doctor S. Choi (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF

Speaker: Doctor Y. Prudat (Lausanne, CH) Doctor P. Pascale (Lausanne, CH)

Access
Abstract
Thumbnail

Volumetric quantification of peri-atrial fat inflammation in atrial fibrillation patients

Speaker: Doctor K. Vickneson (Edinburgh, GB)

Access
Abstract
Slides
Thumbnail

Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers

Speaker: Mrs R. Al-Shama (Amsterdam, NL)

Access
Abstract
Slides
Thumbnail

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort

Speaker: Miss C. Van Deutekom (Groningen, NL)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial Fibrillation - Round 6 - Mechanisms - Pathophysiology

Speakers: Doctor A. Fawzy, Doctor S. Choi, Doctor Y. Prudat, Doctor P. Pascale, Doctor K. Vickneson...
Access
Thumbnail

About the event

Image

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb